Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models.
O'Farrell AC, Jarzabek MA, Lindner AU, Carberry S, Conroy E, Miller IS, Connor K, Shiels L, Zanella ER, Lucantoni F, Lafferty A, White K, Meyer Villamandos MM, Dicker P, Gallagher WM, Keek SA, Sanduleanu S, Lambin P, Woodruff HC, Bertotti A, Trusolino L, Byrne AT, Prehn JHM.
O'Farrell AC, et al. Among authors: jarzabek ma.
Cancers (Basel). 2020 Oct 14;12(10):2978. doi: 10.3390/cancers12102978.
Cancers (Basel). 2020.
PMID: 33066609
Free PMC article.